10 Tips to Combat Coronavirus 10 Tips to Combat Coronavirus

ADVERTISEMENT

New Thought Police NewsGuard Is Owned by Big Pharma

Analysis by Dr. Joseph Mercola Fact Checked

newsguard lacks transparency

Story at-a-glance -

  • NewsGuard is a self-appointed internet watchdog that sells a browser plugin to rate websites on nine criteria of credibility and transparency
  • NewsGuard received much of its startup funds from Publicis Groupe, a giant global communications group
  • Publicis Groupe’s health subsidiary, Publicis Health, names Lilly, Abbot, Roche, Amgen, Genentech, Celgene, Gilead, Biogen, Astra Zeneca, Sanofi, Bayer and other Big Pharma giants as clients
  • In October 2018, GlaxoSmithKline sent its $1.5 billion media account to Publicis
  • In January 2020, GSK awarded Publicis Media with even more business, handing over the former Pfizer Consumer Healthcare Brands to Publicis, a move worth an estimated $400 million
  • While NewsGuard’s warnings may be enough to prevent someone from clicking these links, I believe the true intent is to bury this content entirely from search results and social media feeds

The media is using a variety of tactics to restrict your access to the truth from websites like mine, including NewsGuard, a self-appointed internet watchdog that sells a browser plugin to rate websites on nine criteria of credibility and transparency. Before I delve further into NewsGuard and its underlying agenda, it's important to look at who funds it.

NewsGuard received much of its startup funds from Publicis Groupe, a giant global communications group with divisions that brand imaging, design of digital business platforms, media relations and health care.


Read the Full Article for Free!
Subscribe to the #1 Natural Health Newsletter
  • Unlock censored health information that Google doesn't want you to read
  • Keep your privacy secure — We are no longer active on Facebook and are blocking our content from Google search to ensure your privacy stays protected
  • Get access to all of Dr. Mercola's health articles, E-books and special reports

Existing Subscribers: Enter your email address for instant access